
|Articles|October 17, 2012
Antibody may improve plaque psoriasis
A fully human monoclonal antibody that has been found to inhibit interleukin-17A may significantly improve moderate-to-severe plaque psoriasis, according to new phase 2 study data recently released.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Social Media Mythbusters: Hydrocolloid Pimple Patches
2
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
3
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
4
CSU With Biochemical C1 Inhibitor Deficiency: Case Report Raises Diagnostic Questions
5











